Eucerin DermoPurifyer Skin Renewal Treatment 40ml

Blemish-prone skin

A serum with 10% Hydroxy Complex that unclogs pores, visibly reduces blemishes and helps prevent their re-appearance.

An acid peel for blemish-prone skin

The innovative Eucerin DermoPurifyer Skin Renewal Treatment has been specially formulated to reduce the appearance of pimples, papules and pustules as well as to fade blemish marks. 

It is suitable for all mild to moderate forms of blemished skin and has a triple effect:

  • The 10% Hydroxy Complex contains a highly effective combination of peeling agents − Glycolic Acid, Salicylic Acid and Polyhydroxy Acid – which help to resurface skin, unclog pores, reduce bacteria, remove dead skin cells and prevent new blemishes from appearing

The formula also contains Licochalcone A which has been proven to reduce inflammation and help soothe irritation.

Eucerin DermoPurifyer Skin Renewal Treatment starts to visibly improve skin after just one week, revealing clearer and smoother-looking skin over time.

Can be used during pregnancy but should not be used by skin undergoing medical treatment for blemished skin.

Clinical and dermatological studies

Clinical and dermatological studies prove good skin tolerance and care effectiveness in blemish-prone skin.

Before After eight weeks of use

MAIN FINDINGS

* In a Product in Use (PIU) study 40 men and women (aged 12-44) with acne-prone skin used the product once a day (in the evening) for eight weeks. Results were assessed after one, two, four and eight weeks of use. The before and after images show the visible results after eight weeks of use.

 

In a self-assessment study, 80 women between the ages of 15 and 40 applied Eucerin DermoPurifyer Skin Renewal Treatment 40ml every evening for eight weeks. They reported the following results:

  • 95%: Helps to control the oiliness of skin
  • 94%: Prevents new blemishes from appearing
  • 94%: Reduces dark post-acne marks
  • 94%: Has an anti-shine effect
  • 94%: Smooths the skin’s surface
  • 94%: Visibly improves skin’s appearance
  • 93%: Diminishes the visibility of pores
  • 88%: Visibly reduces blemishes
  • 85%: Reduces whiteheads
  • 83%: Reduces blackheads
  • 81%: Reduces inflammatory pimples 

Frequently Asked Questions

Can I use the serum alongside Benzoyl Peroxide, Antibiotics and treatments for blemished skin with retinoids?

We do not recommend using the serum while you are undergoing medical treatment for blemished skin.

Why is the pH of the Eucerin DermoPurifyer Skin Renewal Treatment important?

The product’s pH plays an important role in its effectiveness and skin compatibility. Eucerin DermoPurifyer Skin Renewal Treatment has a pH of between 3.7 and 3.9. This low, mildly acidic pH is perfect for the role of this product as it increases its antibacterial effect and its ability to remove dead skin cells.

Ingredients

Instructions

  • Use once a day. Preferably in the evening.
  • Apply a small amount (about the size of a pea) to a thoroughly cleansed face
  • Massage gently into skin
  • Follow with an appropriate care product such as Eucerin DermoPurifyer Oil Control Mattifying Fluid
  • Avoid contact with your eyes

Tip: Try out on a small area of skin first. A slight tingling sensation may occur but, if your skin show a visible reaction, consult your dermatologist or pharmacist.

This product contains Alpha Hydroxy Acids that may increase your skin’s sensitivity to the sun and the possibility of sunburn. As a result, we recommend you limit your exposure to the sun while using this product and for a week after. During that period, and after, be sure to apply sun protection in the morning. Try Eucerin Sun Gel-Creme Oil Control SPF30 or 50+.

Recommendations for your daily skincare routine

Cleanse skin in the morning and evening:

  • am: to remove the sebum and dead skin cells that have accumulated overnight
  • pm: to remove make-up and free skin from the day’s dirt

Use gentle cleansing products such as Eucerin DermoPurifyer Oil Control Cleansing Gel with lukewarm water and follow with an appropriate toner. You may also benefit from using a scrub once a week to unclog pores and refine skin texture.

We do not recommend using an alcohol-based toner and the scrub alongside medication for blemished skin as Isotretinoin, Benzoyl Peroxide and Antibiotics can make skin more sensitive. If you like the refreshing feel of a toner, try the alcohol-free Eucerin DermoPurifyer Oil Control Micellar Cleansing Water instead.

The care product you use depends on the severity of your blemished skin and on the type of treatment you are undergoing. 

If you are using medical treatment for blemished skin, Eucerin DermoPurifyer Oil Control Adjunctive Soothing Cream helps to alleviate some of the symptoms such as intense dryness. It should be applied five minutes after your medication so the treatment can absorb fully. 

If you have mild to moderate blemished skin, but are not undergoing medical treatment, use a soothing and mattifying moisturiser such as Eucerin DermoPurifyer Oil Control Mattifying Fluid in the morning and evening.

For clearer and smoother-looking skin over time, you may also like to incorporate our resurfacing treatment into your routine. It is suitable for all blemish-prone skin that is not undergoing medical treatment for blemished skin and should be used once a day only − ideally in the evening. You can use it before the mattifying fluid or on its own.

Sun protection is an important step in your morning routine. Blemishes can cause pigmentation issues if over-exposed to the sun, and medications for blemished skin can make blemish-prone skin even more sensitive to UV rays. Eucerin Sun Gel-Creme Oil Control Dry Touch SPF30 and SPF50+ offers the levels of protection that your skin needs and should be applied before your cover-up and make-up. If you’re applying sun protection after a topical treatment for blemished skin wait five minutes to allow the treatment to fully absorb.  

Do’s and don’ts

Use this product if …

Try a different product if …

You’re looking for a highly effective skin peel or exfoliator for blemish-prone skin:

Eucerin DermoPurifyer Oil Control Resurfacing Treatment starts working from day one and results are visible after just one week.

Your skin is already irritated or irritation occur after use:

Ask your dermatologist or pharmacist for advice

If you are undergoing medical treatment for your blemished skin:

DermoPurifyer Oil Control Effective skin care products for blemish-prone skin

Acne is primarily an inflammatory disease. Inflammation is present at all stages of blemished skin − ranging from non-visible micro-inflammation to visibly inflamed papules and pustules 1 

The Eucerin DermoPurifyer Oil Control range has been specially formulated to work against the main causes of blemish-prone skin:

micro-inflammation: the root cause of the acne cycle
excess sebum production which is also known as seborrhea
hyperkeratosis (a thickening of the external layers of skin) which then leads to blackheads and whiteheads
bacterial growth which leads to visible inflammation in the form of papules and pustules
The formulas include:

  •  Licochalcone A: a highly effective anti-inflammatory that soothes irritations and helps to reduce redness
  •  Salicylic Acid: an antibacterial ingredient with a comedolytic effect that reduces blemishes and prevents them from re-appearing
  •  Sebum-regulating technology: reduces sebum production

The DermoPurifyer Oil Control Resurfacing Treatment also contains:

10% Hydroxy Complex: a highly effective combination of peeling agents (Glycolic-, Salicylic- and Polyhydroxy Acids) that helps to resurface skin, unclog pores, reduce P. blemishes (bacteria) and remove dead skin cells
The range includes mild but effective cleansers and a selection of care products specially formulated for blemish-prone skin many of which are suitable for use alongside medical treatment for blemished skin.

Clinical and dermatological studies prove that the products are compatible with blemish-prone skin and very effective at treating and relieving symptoms

(1) Das S, Reynolds RV: Am J Clin Dermatol (2014), 15: 479-488